Trials / Conditions / EBV-Related Lymphoproliferative Disorder
EBV-Related Lymphoproliferative Disorder
3 registered clinical trials studyying EBV-Related Lymphoproliferative Disorder — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patient NCT06741072 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Recruiting | EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma NCT04664179 | Baylor College of Medicine | Phase 1 |
| Terminated | An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymp NCT05011058 | Viracta Therapeutics, Inc. | Phase 2 |